Stem Cell Research & Publication
Stem Cell is the area of research that studies the advantage of stem cells for the betterment of medical science. All the information related to stem cell therapy with the authentic publication is given below:—
- Stem Cell Therapy for Heart Disease | Stem Cell Therapy for Stroke Disease
- Introduction of Stem Cell Therapy | Stem Cell Therapy for Spinal Cord Injury
- Stem Cell Therapy for Muscular Dystrophy | Mesenchymal Stem Cell for Spinal Cord Injury
- Cardiovascular Regeneration and Stem Cell Therapy | Stem Cell Treatment for Type 1 Diabetes
- Advantage of Stem Cell Therapy for Diabetes Patient | Stem Cell Therapy for Acute Cerebral Injury
- Current Perspectives in Stem Cell Research for Knee Cartilage Repair | Mesenchymal Stem Cell For Autism Patient
- Advantage of Stem Cell Therapy For Autism | Use of Stem Cells for Autism Treatment
- Stem Cell Therapy for Male Infertility | The Stem Cell For Ophthalmology Treatment
- Application of Stem Cells in Orthopedics | Stem Cell Therapies in Orthopedic Trauma
- Mesenchymal Stem Cell Therapy for Osteoarthritis | Mesenchymal Stem Cells in Joint Disease and Repair
- Stem Cell for Retinal and Optic Nerve Diseases | Research Progress of Stem Cells on Glaucomatous Optic Nerve Injury
- Stem Cell Therapy to Improve Visual Acuity in Children with Optic Nerve Hypoplasia
- Stem Cell Therapy for Treatment of Ocular Disorders | Stem Cell Therapy for Retinal Diseases
- Stem Cell Therapy For Cerebral Palsy | Stem Cell Therapy for Muscular Dystrophy
- Mesenchymal Stem Cell Treatment for Chronic Renal Failure | Stem Cell Options for Kidney Disease
- Stem Cell Therapy in Liver Disease | Recent Advances in Liver Stem Cell Therapy
- The Use of Stem Cells in Liver Disease | Stem Cell Therapy, The Great Promise in Lung Disease
- Stem Cell Treatment for Chronic Lung Diseases | Mesenchymal Stem Cell Therapy in Lung Disorders
- Stem Cells and Anti Aging | Stem Cell Aging: Mechanisms, Regulators and Therapeutic Opportunities
- Cell Therapies for Traumatic Brain Injury | Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
- Intravenous Mesenchymal Stem Cell Therapy for Traumatic Brain Injury | Stem Cells and the Treatment of Parkinson’s Disease
- Stem Cell-Based Therapy for Parkinson’s Disease | Stem Cell-Based Approach for the Treatment of Parkinson’s Disease
- Stem Cell-Based Therapies for Multiple Sclerosis | Use of Stem Cells for the Treatment of Multiple Sclerosis
- The Role of Stem Cell Therapy in Multiple Sclerosis | Mesenchymal Stem Cell Therapy in the Sports Knee
- Stem Cells for the Treatment of Skeletal Muscle Injury | Emerging Applications of Stem Cell and Regenerative Medicine to Sports Injuries
- Role of Stem Cells in Treatment of Neurological Disorder | Stem Cells as Promising Therapeutic Options for Neurological Disorders
- Stem Cells for the Treatment of Neurological Disorders | Stem Cell Technology for Neurodegenerative Diseases
- The Current Role of Stem Cells in Orthopaedic Surgery | Stem Cells in Orthopaedics and Fracture Healing
- Clinical Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Osteoarthritis Treatment | Stem Cell Treatment of Degenerative Eye Disease
- Stem Cells in the Eye | Stem Cells and Eye Development
Aging
- Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
- A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ataxia
- Disorders of the Cerebellum: Ataxia, Dysmetria of Thought, and the Cerebellar Cognitive Affective Syndrome
- Falls in degenerative cerebellar ataxias
Diabetes
- Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.
- Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
- Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
- Current Status of Stem Cell Treatment for Type I Diabetes Mellitus
- Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America
- Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetesLes cellules souches mésenchymateuses comme nouvelle approche thérapeutique du diabète de type 1
- Applicability of adipose-derived mesenchymal stem cells in the treatment of patients with type 2 diabetes
- Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
- Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data
- Therapeutic Potential of Mesenchymal Stem Cells for Diabetes
- Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
- Immunomodulation by Mesenchymal Stem Cells
- Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
- Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
- Identifying the Therapeutic Significance of Mesenchymal Stem Cells
Optic Nerve
- Stem cells to replace the optic nerve
- Stem cell therapy for glaucoma: possibilities and practicalities
Osteoarthritis
- Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans.
- Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study.
- Mesenchymal stem cells in osteoarthritis.
- Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis.
Retinitis Pigmentosa
- Human umbilical cord blood-derived stem cells and brain-derived neurotrophic factor protect injured optic nerve: viscoelasticity characterization
- Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve.
- Bone marrow–derived stem cells preserve cone vision in retinitis pigmentosa
- Stem cell treatment of degenerative eye disease
Spinal Cord Injury
- Phase I–II Clinical Trial Assessing Safety and Efficacy of Umbilical Cord Blood Mononuclear Cell Transplant Therapy of Chronic Complete Spinal Cord Injury
- A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury.
- Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.
- Mesenchymal stem cell for prevention and management of intervertebral disc degeneration.
- Treatment of spinal cord injury with mesenchymal stem cells
- Stem Cell Therapy for Spinal Cord Injury
- Progress in Stem Cell Therapy for Spinal Cord Injury
- Stem Cell–Based Therapies for Spinal Cord Injury
- Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials
- Progress in Stem Cell Therapy for Spinal Cord Injury
ALS
- ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles
- Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
- Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
- NurOwn, phase 2, randomized, clinical trial in patients with ALS
- Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS)
- Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in ALS
- Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
- Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside
Alzheimer’s
- Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview
- Stem cell therapy for Alzheimer’s disease
- Alzheimer’s Disease and Stem Cell Therapy
- Immunomodulatory role of mesenchymal stem cells in Alzheimer’s disease
- Stem cell therapies for Alzheimer’s disease
- Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
- Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
- Stem Cell Treatment for Alzheimer’s Disease
- Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
COPD
- Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease
- Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD)
- Mesenchymal stromal cell therapy in COPD: from bench to bedside
- Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell
- Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?
- Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases
- Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science
- Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?
- Mesenchymal stem cells and immunomodulation: current status and future prospects
- Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials
- Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study
Asthma
- Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages
- Mesenchymal Stem Cells Recruit CCR2+ Monocytes to Suppress Allergic Airway Inflammation
Autoimmune
COVID-19
- Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
- The promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
- Taming of Covid-19: potential and emerging application of mesenchymal stem cells
- Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
- Taming of Covid-19: potential and emerging application of mesenchymal stem cells
- The rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
- Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials
Crohn’s Disease
- Immune modulation by mesenchymal stem cells
- Shattering barriers toward clinically meaningful MSC therapies
- Mesenchymal Stem Cells for Perianal Crohn’s Disease
- Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn’s Disease: A Randomized Controlled Clinical Trial
- Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
- Mesenchymal stromal cells: clinical challenges and therapeutic opportunities
- Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review
- Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomized, double-blind controlled trial
Fibromyalgia
Heart Failure
- Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity
- Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue
- Mesenchymal Stem Cells in Cardiology
Immunomodulation
- Mesenchymal stem cells and immunomodulation: current status and future prospects
- Human mesenchymal stem cells modulate allogeneic immune cell responses
Kidney Diseases
- Stem cell-based treatment of kidney diseases
- Stem/progenitor cell in the kidney: characteristics, homing, coordination, and maintenance
- Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
- Stem cells: a potential treatment option for kidney diseases
- Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/Chronic Kidney Disease
- Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases
- Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models
- Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
Liver Disease
- Stem Cell-Based Therapies for Liver Diseases: An Overview and Update
- Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
- Progress in mesenchymal stem cell-based therapy for acute liver failure
- Stem cell transplantation for treating liver diseases: progress and remaining challenges
- Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies
- Systematic review: the effects of autologous stem cell therapy for patients with liver disease
Lupus
- Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
- Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus
- Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients
- Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience
- Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
Lyme Disease
- Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease
- Single-photon emission tomography imaging in patients with Lyme disease treated with human embryonic stem cells
Mesenchymal Stem Cells
- Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
- Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases
- Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Multiple Sclerosis
- The potential use of mesenchymal stem cells for the treatment of multiple sclerosis
- Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
- The Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells as a Novel Cellular Therapy for Multiple Sclerosis
- Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
- Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis
- Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
- Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
- Safety and efficacy of stem cell therapy for the treatment of neural damage in patients with multiple sclerosis
- IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Parkinson’s Disease
- Pluripotent Stem Cell-based therapy for Parkinson’s disease: current status and future prospects
- Mesenchymal stem cell therapy in Parkinson’s disease animal models
- Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
- Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
- Cell replacement therapy for Parkinson’s disease: how close are we to the clinic?
- Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell-Based Therapy for Parkinson’s Disease
- Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
- Stem Cell-Based Therapies for Parkinson’s Disease
Primary Biliary Cirrhosis
Rheumatoid Arthritis
- Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy
- Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications
- Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study
- Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis
- Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
- Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
Stroke
- Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke
- Stem Cell Transplantation Therapy for Multifaceted Therapeutic Benefits after Stroke
- Neuroinflammation as a target for the treatment of stroke using mesenchymal stem cells and extracellular vesicles
- Stem Cell Therapy for Abrogating Stroke-Induced Neuroinflammation and Relevant Secondary Cell Death Mechanisms
- Autologous Mesenchymal Stem Cells in Chronic Stroke
- A Long-Term Follow-Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke
- Efficacy of stem cell-based therapies for stroke
- Recent Advances in Cell-Based Therapies for Ischemic Stroke
Traumatic Brain Injury
- The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury
- Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury
- Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
- Cell-Based therapy for traumatic brain injury
- Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI
- Mesenchymal Stem Cells of Dental Origin-Their Potential for Anti-inflammatory and Regenerative Actions in Brain and Gut Damage
Stem Cell Therapy for Autism
- Stem Cell Therapy for Autism
- Autism
- Autism
- Identification and Evaluation of Children With Autism Spectrum Disorders
- Identification and evaluation of children with autism spectrum disorders
Stem Cell Therapy for Cerebral Palsy
- Treatment of Cerebral Palsy with Stem Cells: A Report of 17 Cases
- Stem cell treatment and cerebral palsy: Systemic review and meta-analysis
- The Role of Stem Cells in the Treatment of Cerebral Palsy: A Review
- Autologous Stem Cell Therapy for Cerebral Palsy
Stem Cell Therapy for Muscular Dystrophy
- Duchenne muscular dystrophy: current cell therapies
- Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
- Stem cell therapy for muscular dystrophy
- Cell therapy strategies and improvements for muscular dystrophy
Stem Cell Therapy for Motor Neuron Disease
- Stem cell technology for the study and treatment of motor neuron diseases
- The Use of Stem Cells in Motor Neurone Disease (MND)
- Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
- Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives
- Stem Cell Therapy in Motor Neuron Disease
- ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles
- Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS)
- Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis
- Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
- Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside
- NurOwn, phase 2, randomized clinical trial in patients with ALS
- Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
- Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy